Delcath Systems Quarterly Cash Flow Statement
NASDAQ: DCTHHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Delcath Systems free cash flow
In the quarter ended Jun 30, 2026, Delcath Systems generated $5.7 million of operating cash flow and spent $503,000 on capital expenditures. That left free cash flow of $5.2 million, a free-cash-flow margin of 17.9% of revenue. Free cash flow was down 24.5% from the prior year's $6.9 million.
Delcath Systems returned $11,000 to shareholders through share repurchases, equal to 0% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Delcath Systems cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 2.67M | -1.07M | -1.90M | 830.00K | 2.70M | 1.07M | -3.40M | 1.86M | -13.74M | -11.11M | -11.14M | -20.34M |
| Net Income growth (YoY) | -1.08% | -200.09% | — | -55.47% | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 100.00K | 102.00K | 80.00K | 100.00K | 100.00K | 43.00K | 38.00K | 100.00K | 100.00K | 29.00K | 41.00K | 100.00K |
| Stock-Based Compensation | 5.12M | 4.95M | 4.51M | 5.65M | 7.21M | 6.86M | 1.61M | 2.14M | 3.07M | 2.94M | 2.00M | 2.83M |
| Change in Working Capital | -1.41M | -2.67M | 5.96M | -1.30M | -1.89M | -5.60M | -5.17M | -4.62M | -3.31M | -2.32M | 1.32M | -1.27M |
| Operating Cash Flow | 5.71M | 857.00K | 8.25M | 4.77M | 7.29M | 2.20M | -1.01M | -3.64M | -4.45M | -9.58M | -8.18M | -9.16M |
| Capital Expenditures | -503.00K | -570.00K | -550.00K | -459.00K | -398.00K | -140.00K | -229.00K | -216.00K | -101.00K | -13.00K | -19.00K | 1.00K |
| Investing Cash Flow | -504.00K | -571.00K | -561.00K | -466.00K | -415.00K | -25.15M | -15.23M | -697.00K | 10.28M | 4.66M | -19.67M | 1.00K |
| Share Repurchases | -11.00K | -3.00M | — | — | 0 | 0 | — | — | — | — | — | — |
| Debt Repaid | — | — | 0 | 0 | 0 | 0 | -2.00M | -2.50M | -3.05M | -3.05M | 0 | 0 |
| Financing Cash Flow | 962.00K | -2.38M | -5.94M | 3.10M | 14.64M | 3.25M | 40.38M | -2.14M | -2.85M | 4.02M | 1.00K | 35.08M |
| Net Change in Cash | 6.21M | -2.14M | 1.64M | 7.39M | 21.64M | -19.64M | 24.10M | -6.47M | 2.97M | -886.00K | -27.82M | 25.92M |
| Free Cash Flow | 5.21M | 287.00K | 7.70M | 4.31M | 6.89M | 2.06M | -1.24M | -3.86M | -4.55M | -9.60M | -8.20M | -9.16M |
This table shows 12 quarterly periods of Delcath Systems's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow DCTH's reporting calendar. What is a cash flow statement?